Evidence map›Paper›PMID 34311181›Full record

ArticleEpilepsy & behavior : E&B2021

Dynamic FDG-PET in localization of focal epilepsy: A pilot study.

Vikram Seshadri, Katherine A Zarroli, Robert S Schetlick, James C Massey, Jose M Reyes, Thomas J Eluvathingal Muttikal, James T Patrie, Stuart S Berr, Nathan B Fountain, Bijoy K Kundu and 1 more

Abstract read
In one paragraph

Article in Epilepsy & behavior : E&B, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Dynamic FDG-PET demonstration of functional brain abnormalities.Annals of clinical and translational neurology · 2022
    Review
  9. Advanced neuroimaging techniques in epilepsy.Current opinion in neurology · 2022
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vikram SeshadriRadiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA.
Katherine A ZarroliDepartment of Neurology, University of Florida Health Jacksonville, Jacksonville, FL, USA.
Robert S SchetlickComputer Science, University of Virginia, Charlottesville, VA, USA.
James C MasseyRadiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA.
Jose M ReyesRadiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA.
Thomas J Eluvathingal MuttikalRadiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA.
James T PatriePublic Health Sciences, University of Virginia, Charlottesville, VA, USA.
Stuart S BerrRadiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA.
Nathan B FountainNeurology, University of Virginia, Charlottesville, VA, USA.
Bijoy K KunduBiomedical Engineering of the University of Virginia, Charlottesville, VA, USA. Electronic address: bkk5a@virginia.edu.
Mark QuiggNeurology, University of Virginia, Charlottesville, VA, USA. Electronic address: quigg@virginia.edu.

Funding

Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)U24NS107182 · NINDS · UNIVERSITY OF VIRGINIA · PI QUIGG, MARK S · 2018 to 2022
$1.6M
NINDS NIH HHS U24 NS107182
6 · The paper itself

Abstract

Epilepsy surgery remains underutilized, in part because non-invasive methods of potential seizure foci localization are inadequate. We used high-resolution, parametric quantification from dynamic 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (dFDG-PET) imaging to locate hypometabolic foci in patients whose standard clinical static PET images were normal. We obtained dFDG-PET brain images with simultaneous EEG in a one-hour acquisition on seven patients with no MRI evidence of focal epilepsy to record uptake and focal radiation decay. Images were attenuation- and motion-corrected and co-registered with high-resolution T1-weighted patient MRI and segmented into 18 regions of interest (ROI) per hemisphere. Tracer uptake was calibrated with a model corrected blood input function with partial volume (PV) corrections to generate tracer parametric maps compared between mean radiation values between hemispheres with z-scores. We identified ROI with the lowest negative z scores (<-1.65 SD) as hypometabolic. Dynamic 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography ( found focal regions of altered metabolism in all cases in which standard clinical FDG-PET found no abnormalities. This pilot study of dynamic FDG-PET suggests that further research is merited to evaluate whether glucose dynamics offer improved clinical utility for localization of epileptic foci over standard static techniques.

Indexed as

Epilepsies, PartialFluorodeoxyglucose F18ElectroencephalographyHumansMagnetic Resonance ImagingPilot ProjectsPositron-Emission TomographyFluorodeoxyglucose F18Cerebral metabolismEpilepsy surgeryFocal epilepsyNeuroimaging

Identifiers

PMID34311181
PMCPMC8436183

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.